Trials / Completed
CompletedNCT01401075
RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients
Prospective Controlled Randomized Comparative Study About Quality of Life (QoL), Immunomodulation and Safety of Adjuvant Mistletoe Treatment in Patients With Gastric Carcinoma Receiving Chemotherapy After Operation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Abnoba Gmbh · Industry
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of safety and efficacy of a standardized mistletoe extract (abnobaVISCUM® Quercus, aVQ) in patients with gastric cancer receiving oral chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mistletoe extract | subcutaneous injections thrice weekly with 1 ml in 4 increasing doses |
| DRUG | doxifluridine | 600 - 900 mg per day orally, depending on weight and status of the patient |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2011-07-25
- Last updated
- 2012-11-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01401075. Inclusion in this directory is not an endorsement.